title: Current Guidelines for Postoperative Treatment and Follow-Up of Well-Differentiated Thyroid Cancer.
abstract: Well-differentiated thyroid cancer is increasing in incidence but the disease-specific mortality remains very low. The only effective adjuvant treatment is radioactive iodine ablation. Guidelines regarding the use and dosage of radioactive iodine depend on pathologic features of the primary and metastatic tumor that define risk. Long-term treatment includes thyroid-stimulating hormone suppression and surveillance with serum thyroglobulin and radiologic assessment for nodal recurrence.
authors.affiliation: Division of Endocrine Surgery, Department of Surgery, University of Pittsburgh, 3471 Fifth Avenue, Kaufman Building, Suite 101, Pittsburgh, PA 15213, USA.
authors.forename: Jenny Y
authors.initials: JY
authors.lastname: Yoo
authors.affiliation: Division of Endocrine Surgery, Department of Surgery, University of Pittsburgh, 3471 Fifth Avenue, Kaufman Building, Suite 101, Pittsburgh, PA 15213, USA. Electronic address: stangmt@upmc.edu.
authors.forename: Michael T
authors.initials: MT
authors.lastname: Stang
mesh_terms: D018263:Adenocarcinoma, Follicular / Q000628:therapy*; D002277:Carcinoma / Q000628:therapy*; D002291:Carcinoma, Papillary; D003131:Combined Modality Therapy / Q000379:methods*; D006801:Humans; D011182:Postoperative Care / Q000379:methods*; D000077273:Thyroid Cancer, Papillary; D013964:Thyroid Neoplasms / Q000628:therapy*
keywords: I(131); Radioactive iodine; TSH suppression; Thyroid cancer